Vor Biopharma Inc. (VOR)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$18.52+$0.0800 (+0.43%) on the dayAs of the close; data may be delayed.
VOR price, last 12 months
Key stats
- Previous close
- $18.44
- Open
- $18.35
- Day range
- $17.95 – $18.71
- 52-week range
- $6.50 – $49.95
- Volume
- 677.7K
- Avg volume (20 days)
- 1.3M
- Market cap
- $1.1B
Performance
1W−13.5%
1M−21.8%
3M+15.0%
6M+36.5%
YTD+41.6%
1Y−46.6%
vs S&P 500, 1Y−63.4 pts
Technicals and fundamentals
About Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $1.1B